论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
动脉粥样硬化动态治疗的最新进展
Authors Wu G, Yu G, Zheng M, Peng W, Li L
Received 26 December 2022
Accepted for publication 6 May 2023
Published 13 July 2023 Volume 2023:18 Pages 3851—3878
DOI https://doi.org/10.2147/IJN.S402678
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Prof. Dr. Anderson Oliveira Lobo
Abstract: Atherosclerosis (AS) is a chronic inflammatory disease, which may lead to high morbidity and mortality. Currently, the clinical treatment strategy for AS is administering drugs and performing surgery. However, advanced therapy strategies are urgently required because of the deficient therapeutic effects of current managements. Increased number of energy conversion-based organic or inorganic materials has been used in cancer and other major disease treatments, bringing hope to patients with the development of nanomedicine and materials. These treatment strategies employ specific nanomaterials with specific own physiochemical properties (external stimuli: light or ultrasound) to promote foam cell apoptosis and cholesterol efflux. Based on the pathological characteristics of vulnerable plaques, energy conversion-based nano-therapy has attracted increasing attention in the field of anti-atherosclerosis. Therefore, this review focuses on recent advances in energy conversion-based treatments. In addition to summarizing the therapeutic effects of various techniques, the regulated pathological processes are highlighted. Finally, the challenges and prospects for further development of dynamic treatment for AS are discussed.
Keywords: atherosclerosis, nanomaterial, physiochemical, reactive oxygen species, energy conversion, therapy